Hong Kong-listed, Nanjing, Jiangsu province-based Simcere Pharmaceutical Group Ltd announced on Monday that Quviviq, an anti-insomnia drug developed in collaboration with the Swiss company ...

Meet woman, daughter of India’s richest pharma tycoon, she now leads Rs 3950000000000 company, she is…, her business is… Vidhi Shanghvi is following in the footsteps of her father Dilip ...

Fintel reports that on June 17, 2025, Citigroup initiated coverage of NewAmsterdam Pharma Company N.V. (NasdaqGM:NAMS) with a Buy recommendation. Analyst Price Forecast Suggests 126.67% Upside As ...

Company announcement – No. 15 / 2025 Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Body weight reductions of a ...

Welcure Drugs & Pharmaceuticals has signed a definitive mandate with Thailand-based Fortune Sagar Impex Company for third-party sourcing and procurement services. The mandate, valued at ₹517 ...

One person died and six others were injured in a blast at a pharma company's unit in Nagpur district on Tuesday, police said. Damaged interior of a pharma company's unit following a blast, at ...

One person has been killed and 6 others are injured in a blast at a pharma company’s unit in Nagpur, the police said on Tuesday. The blast occurred in a glass line reactor of the unit of Ankit ...

NewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have ...

Pharma Stock: A pharmaceuticals company on Tuesday, June 2, said its board will meet on June 13, 2025, to consider a bonus issue of equity shares and dividend payment for 2024-25. The Ahmedabad ...

This announcement further cements LifeSphere NavaX as the innovation driver of choice for global pharma organizations seeking to accelerate, more intelligent workflows across the span of R&D IT ...

Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction. Regeneron said it will acquire 23andMe’s genomics ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the company. The Danish pharmaceutical giant announced Friday that, amidst ...